Why the study?
What are the circulatory effects of intravenous Practolol in patients with acute myocardial infarction?
What are the circulatory effects of intravenous Practolol in patients with acute myocardial infarction?
Practolol demonstrates a favorable hemodynamic profile in acute myocardial infarction by lowering heart rate without severe negative inotropic effects.
Answers are grounded in this paper and cite their sources.
May support low-dose practolol for rate control in acute MI without major compromise; case report leaves open need for randomized trials.
The circulatory effects of Practolol (ICI 50172), a cardio-selective β-adrenergic receptor blocking agent, have been studied in 15 patients during the acute phase of myocardial infarction. A negative chronotropic effect followed doses of 5 and 25 mg given intravenously. In five patients who received the 5 mg dose, the fall in heart rate was not associated with any significant change in cardiovascular function and only a modest negative inotropic effect was observed in the 10 patients who were given 25 mg. Comparison with the known effects of propranolol suggests that Practolol possesses an important advantage when used in patients with myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Jewitt et al. (1970) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: